Citadel Advisors »

Terns Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $420k 65k 6.49
2023-09-30 $549k 109k 5.03
2023-06-30 $408k 47k 8.75
2023-03-31 $4.6M 392k 11.84
2022-12-31 $5.3M 516k 10.18
2022-06-30 $96k 39k 2.48
2021-06-30 $223k 18k 12.25
2021-03-31 $718k 33k 22.01